Log in to save to my catalogue

19 Preclinical CD3-based mouse models for evaluation of bi-specific T-cell engager antibodies

19 Preclinical CD3-based mouse models for evaluation of bi-specific T-cell engager antibodies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_54af7137e1b34521adc6c08c73b5d335

19 Preclinical CD3-based mouse models for evaluation of bi-specific T-cell engager antibodies

About this item

Full title

19 Preclinical CD3-based mouse models for evaluation of bi-specific T-cell engager antibodies

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A21-A21

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundThe T-cell receptor (TCR)- CD3 complex plays a critical role in mediating T-cell activation and cellular immune response. Key signaling subunits of the CD3 co-receptor include CD3ε, CD3δ, and CD3γ. In recent years, an attractive therapeutic approach for cancer treatment uses bispecific antibodies that target human CD3 and a tumor-associat...

Alternative Titles

Full title

19 Preclinical CD3-based mouse models for evaluation of bi-specific T-cell engager antibodies

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_54af7137e1b34521adc6c08c73b5d335

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_54af7137e1b34521adc6c08c73b5d335

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2023-SITC2023.0019

How to access this item